StockDuty ← Dashboard Oct 09, 2026 12:57 PM ET
SignalMacro

City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs

Gene-silencing drugmaker seeks up to $185 million in U.S. IPO.

Gene-silencing drugmaker seeks up to $185 million in U.S. IPO.
Gene-silencing drugmaker seeks up to $185 million in U.S. IPO. — impact context not separately stored; see What changed.
Sources